Experience with Dopamine Agonists in the Treatment of Prolactinomas

Nadiya Barabash, Tetiana M. Tykhonova

Open source

DOI
10.15388/amed.2022.29.2.15
Published
2022-11-22
Container
Acta medica Lituanica
Publisher
Vilnius University Press
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15388/amed.2022.29.2.15,
  title = {Experience with Dopamine Agonists in the Treatment of Prolactinomas},
  author = {Nadiya Barabash and Tetiana M. Tykhonova},
  year = {2022},
  journal = {Acta medica Lituanica},
  doi = {10.15388/amed.2022.29.2.15},
  url = {https://doi.org/10.15388/amed.2022.29.2.15}
}

RIS

TY  - JOUR
TI  - Experience with Dopamine Agonists in the Treatment of Prolactinomas
AU  - Nadiya Barabash
AU  - Tetiana M. Tykhonova
PY  - 2022
JO  - Acta medica Lituanica
DO  - 10.15388/amed.2022.29.2.15
UR  - https://doi.org/10.15388/amed.2022.29.2.15
ER  - 

APA

Barabash, N., & Tykhonova, T. M. (2022). Experience with Dopamine Agonists in the Treatment of Prolactinomas. Acta medica Lituanica. https://doi.org/10.15388/amed.2022.29.2.15

Source records